Microfluidic device as a novel cell transmigration assay by Kwasny, Dorota et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 19, 2017
Microfluidic device as a novel cell transmigration assay
Kwasny, Dorota; Kiilerich-Pedersen, Katrine; Moresco, Jacob Lange; Dimaki, Maria; Rozlosnik, Noemi;
Svendsen, Winnie Edith
Publication date:
2011
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Kwasny, D., Kiilerich-Pedersen, K., Moresco, J. L., Dimaki, M., Rozlosnik, N., & Svendsen, W. E. (2011).
Microfluidic device as a novel cell transmigration assay. Abstract from NanoBioTech Conference, Montreux
(CH), 14-16 Nov, .
Presentation preference - Oral Presentation 
Topic – Medicine – Cell Analysis Systems 
 
Microfluidic device as a novel cell transmigration assay 
 
Dorota Kwasny*
*Technical University of Denmark, DTU Nanotech, Denmark 
, Katrine Kiilerich-Pedersen*, Jacob Moresco**, Maria Dimaki*, Noemi Rozlosnik* and 
Winnie E. Svendsen* 
**Currently at Sunstone Capital DK, Denmark 
 
Leukocytes circulating in blood transmigrate through vessel walls in a multistep process induced by 
chemoattractants [1]. The current method for cell migration studies is a static, membrane based end-point assay 
called a Boyden chamber that enables cell quantification after migration, but no means are available to track the 
process [2]. Contrary, in an alternative assay called a shear flow chamber, the cells cannot truly transmigrate 
through a layer of endothelial cells, as there is a solid support underneath [3]. The microfluidic migration assay 
presented here combines the principles of both assays to enable observation of the entire transmigration process 
under physiological flow conditions. 
 
The microfluidic device, fabricated by micromilling in two poly(methylmethacrylate) (PMMA) plates, is 
composed of two straight channels physically separated by a polycarbonate membrane, assembled together by 
thermal bonding (Fig.1). Continuous flow of cells and chemoattractant solutions at 1.67x10-3 m/s in both channels 
assures that a stable chemoattractant gradient is formed across the membrane. This was validated with Comsol 
simulations (Fig.2). The cells transmigrate through the membrane from the top channel (cell channel) to the 
bottom channel (chemoattractant channel). To mimic the natural environment of migrating cells, cell adhesion 
proteins were injected to the cell channel after bonding for coating of the membrane and channel walls. The 
behavior of labeled Jurkat cells and purified lymphocytes in the devices coated with fibronectin (Fn) or vascular 
cell adhesion molecule-1 (VCAM-1) was recorded. Figure3 illustrates the cell velocity change with time. 
 
Microscopic observations of Jurkat cells migrating on a Fn coated surface demonstrated tight adhesion to the 
surface followed by crawling to transmigrate through a pore. In a separate experiment, Jurkat cells (Fig.3) and 
lymphocytes were first rolling on the membrane coated with VCAM-1 before adhesion and transmigration. At 
average, cell velocity during rolling was 150x10-6 m/s, which is significantly lower than the flow velocity 
calculated at 5 µm distance from the channel wall (475x10-6 m/s). Such slow cell movement demonstrates weak 
bonds formed between cells and VCAM-1, which are broken due to shear flow. Further decrease in cell velocity 
is interpreted as a strong adhesion of cells to the membrane, induced by chemoattractant activation of cell surface 
integrins. After transmigration through the pores when the cells join the chemoattractant flow in the other 
channel, the velocity of all analyzed cells rapidly increases. 
 
The presented microfluidic migration device imitates the physiological flow conditions for reliable cell 
transmigration studies. It can be applied in basic research or drugs development as it offers a significant reduction 
of sample volume used, it is inexpensive, easy to fabricate, disposable and amenable for high throughput analysis. 
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Figure 1 A schematic drawing of the three elements of the 
device (1-cell channel, 2-membrane, 3-chemoattractant channel) 
during assembling (A). A complete device for cell migration 
studies (B). 
 
Figure 2 Simulation of the chemoattractant concentration 
gradient formed across the membrane in the device. The 
concentration is evaluated 5 µm above the membrane and 
changes with time and channel length. 
 
Figure 3 Graph of Jurkat cell velocity as a function of time on a 
VCAM-1 surface. The initial behavior of a slightly decreasing 
velocity indicates rolling. This is followed by a region of 
constant cell velocity, the length of which is different for each 
cell, and which occurs due to adhesion. The dashed line 
indicates the transmigration though pores (normalized as time 
0). After transmigration there is a rapid linear increase in cell 
velocity, as the cells exit into the chemoattractant channel and 
simply follow the flow. 
 
 
 
